In the context of nonalcoholic fatty liver disease (NAFLD), PAI-1 overexpression is known to contribute to hepatic steatosis by promoting lipid accumulation and disrupting lipid homeostasis. This evidence concerns the gene SERPINE1 and metabolic dysfunction-associated steatotic liver disease.